Teva Gains Another $2.48 Billion For Selling The Last Of Its Women???s Health Portfolio Post author:Sam Post published:September 17, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Cutera Strengthens Leadership Team With Two Key Executive Appointments August 20, 2017 Mallinckrodt Takes Out Sucampo in Surprising $1.2B Deal December 26, 2017 Teva Sees Approval at Finish Line for Anti-CGRP Migraine Treatment December 21, 2017